AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588307. A total of 61 filers reported holding AVEO PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $9,000 | -30.8% | 566 | -65.4% | 0.00% | – |
| Q3 2022 | $13,000 | +30.0% | 1,636 | +4.5% | 0.00% | – |
| Q2 2022 | $10,000 | -16.7% | 1,565 | -28.5% | 0.00% | – |
| Q1 2022 | $12,000 | +9.1% | 2,190 | -10.1% | 0.00% | – |
| Q4 2021 | $11,000 | 0.0% | 2,435 | +50.8% | 0.00% | – |
| Q3 2021 | $11,000 | 0.0% | 1,615 | -1.5% | 0.00% | – |
| Q2 2021 | $11,000 | -21.4% | 1,640 | -13.9% | 0.00% | – |
| Q1 2021 | $14,000 | +100.0% | 1,904 | +56.1% | 0.00% | – |
| Q4 2020 | $7,000 | +250.0% | 1,220 | +269.7% | 0.00% | – |
| Q3 2020 | $2,000 | 0.0% | 330 | -23.3% | 0.00% | – |
| Q2 2020 | $2,000 | 0.0% | 430 | 0.0% | 0.00% | – |
| Q1 2020 | $2,000 | – | 430 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 1,986,176 | $12,275,000 | 2.58% |
| Worth Venture Partners, LLC | 454,364 | $2,808,000 | 1.26% |
| Opaleye Management Inc. | 455,600 | $2,816,000 | 0.53% |
| J. Goldman & Co LP | 1,663,229 | $10,279,000 | 0.52% |
| X-Square Capital, LLC | 92,283 | $570,000 | 0.30% |
| NEA Management Company, LLC | 3,952,958 | $24,429,000 | 0.29% |
| Birchview Capital, LP | 40,000 | $247,000 | 0.17% |
| PERSONAL CFO SOLUTIONS, LLC | 23,000 | $142,000 | 0.03% |
| PURA VIDA INVESTMENTS, LLC | 147,574 | $912,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 35,232 | $218,000 | 0.02% |